FDA Adverse Event Injury Summary report: N

INRATIO

MDR report key: 1173455 · Received September 23, 2008

Report

Report Number
2954730-2008-00568
Event Type
Injury
Date Received
September 23, 2008
Date of Event
September 8, 2008
Report Date
September 19, 2008
Manufacturer
HEMOSENSE, INC.
Product Code
JPA
Removal / Correction Number
NI
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

DISCREPANT RESULTS (ACCURACY) COMPARISON OF INRATIO TEST WITH LAB RESULTS PROVIDED BY END-USER AT TIME COMPLAINT WAS FILED: DATE: 2008; INRATIO: 6.3; LAB: 9.2; MEAN: 7.75; CONFIDENT LIMITS: NOT WITHIN THE CONFIDENT LIMIT. REV. 2 SECTION 10.1 THE MEAN IS GREATER THAN 5 WHICH IS 7.75 AND DIFFERENCE IN INR'S IS GREATER THAN 2.2 WHICH 2.9. ACCEPTANCE RANGE IS INACCURATE. THE PRODUCT WILL BE INVESTIGATED. PT COUMADIN WAS HELD. THIS EVENT IS AN ADVERSE EVENT. ALSO PT IS NOW WITHIN THE NORMAL RANGE 3.1.

Description of Event or Problem · 1

THE CALLER ALLEGED DISCREPANT RESULTS WHEN COMPARED WITH THE LAB RESULTS REPORTED AS FOLLOWS: DATE: 2008; INRATIO: 6.3; LAB: 9.2.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 INRATIO PROTHROMBIN TIME TEST JPA HEMOSENSE, INC. 0100004 NP

Patients

Seq Age Sex Outcome Treatment
1 NI